🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
This phase 2 trial will investigate the efficacy and safety of trametinib a...
Status
Completed
Location
Universitair Ziekenhuis Brussel
Start Date
2019-01-28
Trial ID
NCT04059224
Treatments Being Tested
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The purpose of this study is to find out whether a drug called PDR001, comb...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2020-09-02
Trial ID
NCT04544111
Treatments Being Tested
The purpose of this Treatment Plan is to allow access to trametinib and dab...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04544202
Treatments Being Tested
The aim of the study was to evaluate the effectiveness of combination thera...
Status
Withdrawn
Location
Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of High Medical Technologies
Start Date
2021-01-22
Trial ID
NCT04739566
Treatments Being Tested
The purpose of this Cohort Treatment Plan is to allow access to trametinib ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04489433
Treatments Being Tested
This was a Phase II, open-label, non-randomized, multi-center study of oral...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-03-12
Trial ID
NCT02034110
Treatments Being Tested
The study is being conducted to evaluate the effect of rifampin (a strong C...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-12-20
Trial ID
NCT01954043
Treatments Being Tested
This is a Japanese Phase I/II, open-label, non-controlled study to evaluate...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-15
Trial ID
NCT01928940
Treatments Being Tested